These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9241133)
21. Glucocorticoid-induced osteoporosis: summary of a workshop. Canalis E; Giustina A J Clin Endocrinol Metab; 2001 Dec; 86(12):5681-5. PubMed ID: 11739419 [No Abstract] [Full Text] [Related]
22. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium. Sambrook PN; Kotowicz M; Nash P; Styles CB; Naganathan V; Henderson-Briffa KN; Eisman JA; Nicholson GC J Bone Miner Res; 2003 May; 18(5):919-24. PubMed ID: 12733733 [TBL] [Abstract][Full Text] [Related]
24. Prevention of glucocorticoid-induced osteoporosis: why are we doing so poorly? Yood RA J Rheumatol; 2006 Aug; 33(8):1461-3. PubMed ID: 16881101 [No Abstract] [Full Text] [Related]
25. Balancing bones and bucks among new glucocorticoid users. Saag KG; Pisu M J Rheumatol; 2003 Jan; 30(1):1-3. PubMed ID: 12508381 [No Abstract] [Full Text] [Related]
26. What is new in the treatment of steroid-induced osteoporosis? Liu RH; Werth VP Semin Cutan Med Surg; 2007 Dec; 26(4):203-9. PubMed ID: 18395668 [TBL] [Abstract][Full Text] [Related]
27. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men. Cruse LM; Valeriano J; Vasey FB; Carter JD J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807 [TBL] [Abstract][Full Text] [Related]
29. Effect of glucocorticoids on bone density. Rehman Q; Lane NE Med Pediatr Oncol; 2003 Sep; 41(3):212-6. PubMed ID: 12868121 [TBL] [Abstract][Full Text] [Related]
30. Didronel PMO. Stone M Br J Hosp Med; 1993 Feb 17-Mar 2; 49(4):275-7. PubMed ID: 8443628 [TBL] [Abstract][Full Text] [Related]
32. Prevention and management of glucocorticoid-induced osteoporosis. Lane NE; Mroczkowski PJ; Hochberg MC Bull Rheum Dis; 1995 Aug; 44(5):1-4. PubMed ID: 7550788 [No Abstract] [Full Text] [Related]
33. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone. Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473 [TBL] [Abstract][Full Text] [Related]
34. Glucocorticoid-induced osteoporosis. de Gregório LH; Lacativa PG; Melazzi AC; Russo LA Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):793-801. PubMed ID: 17117304 [TBL] [Abstract][Full Text] [Related]
35. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial. Stoch SA; Saag KG; Greenwald M; Sebba AI; Cohen S; Verbruggen N; Giezek H; West J; Schnitzer TJ J Rheumatol; 2009 Aug; 36(8):1705-14. PubMed ID: 19487264 [TBL] [Abstract][Full Text] [Related]
36. Corticosteroids: no drug prevention of fractures needed. Prescrire Int; 2009 Aug; 18(102):175. PubMed ID: 19746563 [TBL] [Abstract][Full Text] [Related]
37. Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup. Sato S; Takada T; Katsuki Y; Kimura N; Kaneko Y; Suwa A; Hirakata M; Kuwana M J Rheumatol; 2008 Jan; 35(1):142-6. PubMed ID: 18050368 [TBL] [Abstract][Full Text] [Related]